ENSG
The Ensign Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth -10.5% ·
share flow +5.9% ·
net new positions -17.6%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 19.50K | $1.62M | n/a | −1 |
| Q2 2026 | 127 | -2 | 36.17M | $5.80B | +9 | −13 |
| Q1 2026 | 134 | +5 | 36.99M | $7.45B | +10 | −6 |
| Q4 2025 | 128 | +3 | 40.66M | $7.09B | +5 | −1 |
| Q3 2025 | 17 | -2 | 26.18M | $4.52B | n/a | −3 |
| Q2 2025 | 17 | +1 | 23.71M | $3.66B | +2 | −1 |
| Q1 2025 | 13 | -2 | 7.38M | $955.63M | +1 | −3 |
| Q4 2024 | 15 | 0 | 7.55M | $1.00B | +1 | −1 |
| Q3 2024 | 14 | +3 | 5.81M | $836.31M | +3 | n/a |
| Q2 2024 | 11 | n/a | 3.54M | $438.25M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.05M | -2.1% | $1.22B | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passive) | 6.07M | -0.9% | $1.05B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Baillie Gifford ✦ | 2.82M | +96.2% | $486.97M | 0.4% | ▲ Add | 5 | SEC ↗ ×4 |
| 4 | Fidelity (FMR) ✦ | 2.61M | -3.7% | $450.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 5 | State Street Global Advisors ✦ (passive) | 2.05M | -1.5% | $353.77M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 1.45M | +0.8% | $250.47M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 1.21M | +105.2% | $209.81M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | JPMorgan Chase ✦ | 867.20K | n/a | $149.83M | 0.0% | n/c | 1 | SEC ↗ ×26 |
| 9 | Wellington Management ✦ | 821.92K | -6.0% | $142.00M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 10 | Morgan Stanley ✦ | 444.83K | n/a | $76.85M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 11 | Goldman Sachs Group ✦ | 384.80K | n/a | $66.48M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Arrowstreet Capital ✦ | 352.12K | +31.7% | $60.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 20.59K | -37.1% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 14 | Marshall Wace ✦ | 14.46K | -85.2% | $2.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 10.53K | -0.8% | $1.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 6.74K | +271.0% | $1.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 2.86K | -88.0% | $494,813 | 0.0% | ▼ Trim | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Norges Bank | $105.40M | was 0.0% |
| Millennium Management | $13.53M | was 0.0% |
| Citadel Advisors | $7.60M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 566 holders, 52.97M shares, $9.97B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 100 sh · $17,962
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology